Be the catalystVisit our new Scientific Hub here
PAION AG grants license to YICHANG Humanwell for Remimazolam in China
PAION Receives Euro 20 Million for Sale of Remaining Desmoteplase Rights to H. Lundbeck A/S
Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.
